Abstract
A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.
MeSH terms
-
Adult
-
Anthracyclines / pharmacology
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Bridged-Ring Compounds / pharmacology
-
Chemotherapy, Adjuvant
-
Cyclophosphamide / administration & dosage
-
Drug Administration Schedule
-
Drug Resistance, Neoplasm
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / secondary*
-
Lymphangitis / etiology
-
Methotrexate / administration & dosage
-
Quality of Life
-
Remission Induction
-
Tamoxifen / administration & dosage
-
Taxoids / pharmacology
Substances
-
Anthracyclines
-
Antineoplastic Agents, Hormonal
-
Bridged-Ring Compounds
-
Taxoids
-
Tamoxifen
-
taxane
-
Cyclophosphamide
-
Fluorouracil
-
Methotrexate